The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 3, 2009, Pages 315-325

  Zaia, John A ^a   Sun, Joel Y ^b   Gallez Hawkins, Ghislaine M ^a   Thao, Lia ^a   Oki, Arisa ^b   Lacey, Simon F ^c   Dagis, Andrew ^b   Palmer, Joycelynne ^b   Diamond, Don J ^c   Forman, Stephen J ^b   Senitzer, David ^b  

^a City of Hope   (United States)

^b NONE   (United States)

^c Division of Translational Vaccine Research   (United States)

Author keywords

Cell transplantation; Cytomegalovirus; KIR genotypes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GANCICLOVIR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; STEROID; VIRUS DNA;

ADULT; ARTICLE; CASE STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; DONOR SELECTION; FEMALE; GENOTYPE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PATIENT MONITORING; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; VIRUS IMMUNITY; VIRUS REACTIVATION;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, KIR; TISSUE DONORS; VIRUS ACTIVATION;

EID: 59349107198     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.11.030     Document Type: Article

References (31)

1. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
2. Gerosa F., Gobbi A., Zorzi P., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
3. Moretta A., Marcenaro E., Parolini S., Ferlazzo G., and Moretta L. NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15 (2008) 226-233
4. Vilches C., and Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20 (2002) 217-251
5. Carrington M., and Martin M.P. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 298 (2006) 225-257
6. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 (2008) 259-268
7. Ljunggren H.G., and Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244
8. Witt C.S., and Christiansen F.T. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang 90 (2006) 10-20
9. Ruggeri L., Capanni M., Casucci M., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339
10. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
11. Giebel S., Locatelli F., Lamparelli T., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814-819
12. Sun J.Y., Dagis A., Gaidulis L., et al. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients. Biol Blood Marrow Transplant 13 (2007) 197-205
13. McQueen K.L., Dorighi K.M., Guethlein L.A., Wong R., Sanjanwala B., and Parham P. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum Immunol 68 (2007) 309-323
14. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
15. Romero V., Azocar J., Zuniga J., et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome. Mol Immunol 45 (2008) 2429-2436
16. Jennes W., Verheyden S., Demanet C., et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177 (2006) 6588-6592
17. Alter G., Martin M.P., Teigen N., et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204 (2007) 3027-3036
18. Cook M., Briggs D., Craddock C., et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107 (2006) 1230-1232
19. Chen C., Busson M., Rocha V., et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 38 (2006) 437-444
20. Uhrberg M., Valiante N.M., Shum B.P., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 7 (1997) 753-763
21. Gallez-Hawkins G., Thao L., Lacey S.F., et al. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection. Biol Blood Marrow Transplant 11 (2005) 890-902
22. Gleaves C.A., Smith T.F., Shuster E.A., and Pearson G.R. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 21 (1985) 217-221
23. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34 (2002) 1094-1097
24. Sun J.Y., Gaidulis L., Miller M.M., et al. Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 64 (2004) 462-468
25. Sun J.Y., Gaidulis L., Dagis A., et al. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML. Bone Marrow Transplant 36 (2005) 525-530
26. Hsu K.C., Liu X.R., Selvakumar A., Mickelson E., O'Reilly R.J., and Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 (2002) 5118-5129
27. Yu J., Heller G., Chewning J., Kim S., Yokoyama W.M., and Hsu K.C. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 179 (2007) 5977-5989
28. Uhrberg M. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol Immunol 42 (2005) 471-475
29. Hokeness K.L., Kuziel W.A., Biron C.A., and Salazar-Mather T.P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 174 (2005) 1549-1556
30. Robbins S.H., Bessou G., Cornillon A., et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 3 (2007) e123
31. Su H.C., Nguyen K.B., Salazar-Mather T.P., Ruzek M.C., Dalod M.Y., and Biron C.A. NK cell functions restrain T cell responses during viral infections. Eur J Immunol 31 (2001) 3048-3055